[Elsevier] LANCET - Efficacy and safety of oral orforglipron in Japanese participants with obesity disease (ATTAIN-J): a double-blind, randomised, placebo-controlled, parallel-group, phase 3 trial |
|
This post will be closed automatically in 2026-11-07 03:18
Reward40points
|
| |
post
reply
points
8485
10
Synthesis, characterization and photophysical interaction studies of sulfamethoxazole azo dyes: evaluation for antioxidant, anticancer, and latent fingerprint probing applications
10
ASOC Osuntokun Award Lecture 2022: Partnership for stroke prevention and treatment in Africa: Qualitative research processes and findings
10
A scoping review of factors associated with self-management in young adults with stroke
50
[Full book] Current Therapy of Trauma and Surgical Critical Care 2026
20
ZnO sintering additive without negative impact on proton-conducting SrHf0.8Sc0.2O3-δ electrolyte
